The Aralez portfolio of approved products is anchored in cardiovascular disease and plans for continued development and growth in this and other specialty areas.

Cardiovascular
Product | Status | Territories |
![]() |
Marketed |
|
![]() |
Marketed |
|
![]() |
Marketed |
|
Pain/Inflammation
Product | Status | Territories |
![]() |
Marketed |
|
![]() |
Marketed |
|
![]() |
Marketed |
|
![]() |
Marketed |
|
![]() |
Marketed |
|
![]() |
Marketed |
|
![]() |
Marketed |
|
Other Products
DERMATOLOGY
Product | Status | Territories |
![]() |
Marketed |
|
![]() |
Marketed |
|
GASTROINTESTINAL
NONPRESCRIPTION PRODUCTS
Product | Status | Territories |
![]() |
Marketed |
|
![]() |
Marketed |
|
![]() |
Marketed |
|
OTHER
NONPRESCRIPTION PRODUCTS
Product | Status | Territories |
![]() |
Marketed |
|
![]() |
Marketed |
|
![]() |
Marketed |
|